Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $20.87 Analyst target: $88.00 Upside: 321.66%
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biological drugs for the selective modulation of the human immune system to treat a variety of cancers, chronic infectious diseases, and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.